Use of abciximab prevents microcirculato
โ
Francesco Prati; Piotr Kwiatkowski; Constantino Caroselli; Fabrizio Imola; Aless
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 63 KB
๐ 2 views
The use of abciximab during percutaneous coronary angioplasty (PTCA) in patients with unstable angina (UA) prevents the postintervention enzyme surge and improves clinical outcomes, possibly by improving microcirculatory function. The aim of this quantitative myocardial blush grade (MBG) study was t